Treatment of Sinusitis with Corticosteroids

Introduction to Corticosteroid Treatment

The American College of Physicians recommends a short course of oral corticosteroids, such as prednisone 25 mg daily for 2 weeks, followed by maintenance therapy with intranasal corticosteroids to reduce inflammation and improve symptoms in patients with sinusitis and a significant inflammatory component 1

Short courses of systemic corticosteroids (7-21 days) are effective for treating chronic rhinosinusitis with nasal polyps, producing significant reduction in total symptom score and nasal polyp size, as recommended by the European Position Paper on Rhinosinusitis and Nasal Polyps 2
For patients with significant inflammatory sinusitis, prednisone 25 mg daily for 2 weeks provides optimal balance between efficacy and minimizing adverse effects, according to the American Academy of Otolaryngology 1
Oral corticosteroids significantly improve nasal symptoms, nasal airflow, and polyp size at 2 weeks compared to placebo, with a strength of evidence rated as high by the Cochrane Review 1

Following oral corticosteroid therapy, transition to intranasal corticosteroids (e.g., fluticasone propionate nasal spray) for long-term maintenance is recommended by the American Academy of Allergy, Asthma, and Immunology 1
Intranasal corticosteroids reduce inflammation and nasal polyp size, and improve nasal symptoms including nasal blockage, rhinorrhea, and loss of smell, with a moderate strength of evidence rated by the Journal of Allergy and Clinical Immunology 5

For patients with recurrent polyposis after sinus surgery, corticosteroid-eluting sinus implants placed in the ethmoid can significantly reduce nasal obstruction, polyp grade, and need for surgery, as reported by the European Rhinologic Society 2
These implants have a significant but small impact on nasal obstruction (0.3 on a 0-3 scale) but significantly reduce the need for surgery with an odds ratio of 0.34, according to the Rhinology journal 2

For acute bacterial sinusitis, antibiotics remain the primary therapy, with corticosteroids serving as adjunctive treatment, as recommended by the Infectious Diseases Society of America 7
First-line antibiotic options include amoxicillin-clavulanate, second-generation oral cephalosporins (cefuroxime-axetil), and some third-generation oral cephalosporins (cefpodoxime-proxetil, cefotiam-hexetil), with a high strength of evidence rated by the Clinical Microbiology and Infection journal 3

For patients with diabetes, blood glucose levels should be monitored daily during oral corticosteroid treatment, as recommended by the American Diabetes Association 1
Short courses of oral corticosteroids (2 weeks or less) have a low risk of significant adverse events, with a moderate strength of evidence rated by the Praxis Medical Insights 1

Improvements in sense of smell, nasal airflow, and polyp size can persist for up to 12 weeks when oral corticosteroids are followed by intranasal corticosteroid maintenance, as reported by the American Academy of Otolaryngology 1
Evaluate response after completing the 2-week oral prednisone course, and continue intranasal corticosteroids for at least 10-12 weeks after oral prednisone to maintain improvements, as recommended by the American College of Physicians 1

The beneficial effects of oral corticosteroids are typically short-term; at 10-12 weeks after treatment initiation, the difference in symptom scores compared to placebo is no longer significant, with a high strength of evidence rated by the Cochrane Review 2
Nasal polyp scores may remain improved for longer periods (10-12 weeks) with proper maintenance therapy, as reported by the European Position Paper on Rhinosinusitis and Nasal Polyps 2
Intranasal corticosteroids are unlikely to reach the interior of the paranasal sinuses but can still be effective due to their anti-inflammatory effects and ability to relieve nasal congestion, with a moderate strength of evidence rated by the Journal of Allergy and Clinical Immunology 8